Cargando…
Development of a high throughput PCR to detect Coxiella burnetii and its application in a diagnostic laboratory over a 7-year period
Q fever is a worldwide zoonotic infectious disease due to Coxiella burnetii. The clinical presentation may be acute (pneumonia and/or hepatitis) or chronic (most commonly endocarditis). Diagnosis mainly relies on serology and PCR. We therefore developed a quantitative real-time PCR. We first tested...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184484/ https://www.ncbi.nlm.nih.gov/pubmed/25356317 http://dx.doi.org/10.1002/2052-2975.8 |
_version_ | 1782337847237279744 |
---|---|
author | Jaton, K Peter, O Raoult, D Tissot, J-D Greub, G |
author_facet | Jaton, K Peter, O Raoult, D Tissot, J-D Greub, G |
author_sort | Jaton, K |
collection | PubMed |
description | Q fever is a worldwide zoonotic infectious disease due to Coxiella burnetii. The clinical presentation may be acute (pneumonia and/or hepatitis) or chronic (most commonly endocarditis). Diagnosis mainly relies on serology and PCR. We therefore developed a quantitative real-time PCR. We first tested blindly its performance on various clinical samples and then, when thoroughly validated, we applied it during a 7-year period for the diagnosis of both acute and persistent C. burnetii infection. Analytical sensitivity (< 10 copies/PCR) was excellent. When tested blindly on 183 samples, the specificity of the PCR was 100% (142/142) and the sensitivity was 71% (29/41). The sensitivity was 88% (7/8) on valvular samples, 69% (20/29) on blood samples and 50% (2/4) on urine samples. This new quantitative PCR was then successfully applied for the diagnosis of acute Q fever and endovascular infection due to C. burnetii, allowing the diagnosis of Q fever in six patients over a 7-year period. During a local small cluster of cases, the PCR was also applied to blood from 1355 blood donors; all were negative confirming the high specificity of this test. In conclusion, we developed a highly specific method with excellent sensitivity, which may be used on sera for the diagnosis of acute Q fever and on various samples such as sera, valvular samples, aortic specimens, bone and liver, for the diagnosis of persistent C. burnetii infection. |
format | Online Article Text |
id | pubmed-4184484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-41844842014-10-29 Development of a high throughput PCR to detect Coxiella burnetii and its application in a diagnostic laboratory over a 7-year period Jaton, K Peter, O Raoult, D Tissot, J-D Greub, G New Microbes New Infect New Microbes in Humans – New Resistant Microbes in Humans Q fever is a worldwide zoonotic infectious disease due to Coxiella burnetii. The clinical presentation may be acute (pneumonia and/or hepatitis) or chronic (most commonly endocarditis). Diagnosis mainly relies on serology and PCR. We therefore developed a quantitative real-time PCR. We first tested blindly its performance on various clinical samples and then, when thoroughly validated, we applied it during a 7-year period for the diagnosis of both acute and persistent C. burnetii infection. Analytical sensitivity (< 10 copies/PCR) was excellent. When tested blindly on 183 samples, the specificity of the PCR was 100% (142/142) and the sensitivity was 71% (29/41). The sensitivity was 88% (7/8) on valvular samples, 69% (20/29) on blood samples and 50% (2/4) on urine samples. This new quantitative PCR was then successfully applied for the diagnosis of acute Q fever and endovascular infection due to C. burnetii, allowing the diagnosis of Q fever in six patients over a 7-year period. During a local small cluster of cases, the PCR was also applied to blood from 1355 blood donors; all were negative confirming the high specificity of this test. In conclusion, we developed a highly specific method with excellent sensitivity, which may be used on sera for the diagnosis of acute Q fever and on various samples such as sera, valvular samples, aortic specimens, bone and liver, for the diagnosis of persistent C. burnetii infection. BlackWell Publishing Ltd 2013-10 2013-09-18 /pmc/articles/PMC4184484/ /pubmed/25356317 http://dx.doi.org/10.1002/2052-2975.8 Text en © 2013 The Authors. New Microbes and New Infections published by John Wiley & Sons Ltd on behalf of the European Society of Clinical Microbiology and Infectious Disease. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | New Microbes in Humans – New Resistant Microbes in Humans Jaton, K Peter, O Raoult, D Tissot, J-D Greub, G Development of a high throughput PCR to detect Coxiella burnetii and its application in a diagnostic laboratory over a 7-year period |
title | Development of a high throughput PCR to detect Coxiella burnetii and its application in a diagnostic laboratory over a 7-year period |
title_full | Development of a high throughput PCR to detect Coxiella burnetii and its application in a diagnostic laboratory over a 7-year period |
title_fullStr | Development of a high throughput PCR to detect Coxiella burnetii and its application in a diagnostic laboratory over a 7-year period |
title_full_unstemmed | Development of a high throughput PCR to detect Coxiella burnetii and its application in a diagnostic laboratory over a 7-year period |
title_short | Development of a high throughput PCR to detect Coxiella burnetii and its application in a diagnostic laboratory over a 7-year period |
title_sort | development of a high throughput pcr to detect coxiella burnetii and its application in a diagnostic laboratory over a 7-year period |
topic | New Microbes in Humans – New Resistant Microbes in Humans |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184484/ https://www.ncbi.nlm.nih.gov/pubmed/25356317 http://dx.doi.org/10.1002/2052-2975.8 |
work_keys_str_mv | AT jatonk developmentofahighthroughputpcrtodetectcoxiellaburnetiianditsapplicationinadiagnosticlaboratoryovera7yearperiod AT petero developmentofahighthroughputpcrtodetectcoxiellaburnetiianditsapplicationinadiagnosticlaboratoryovera7yearperiod AT raoultd developmentofahighthroughputpcrtodetectcoxiellaburnetiianditsapplicationinadiagnosticlaboratoryovera7yearperiod AT tissotjd developmentofahighthroughputpcrtodetectcoxiellaburnetiianditsapplicationinadiagnosticlaboratoryovera7yearperiod AT greubg developmentofahighthroughputpcrtodetectcoxiellaburnetiianditsapplicationinadiagnosticlaboratoryovera7yearperiod |